Literature DB >> 2158835

The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater.

M G Buzzi1, M A Moskowitz.   

Abstract

1. We describe the actions of GR43175, a 5-hydroxytryptamine1 (5-HT1)-like receptor agonist, on neurogenically-mediated plasma protein extravasation within an important pain-sensitive intracranial tissue, the dura mater. 2. GR43175 markedly attenuated extravasation of 125I-albumin from blood vessels within ipsilateral dura mater when administered to rats (100 micrograms kg-1) fifteen minutes before unilateral electrical trigeminal stimulation (1.2 mA, 5 Hz, 5 ms, 5 min); the ratio (stimulated/unstimulated sides) decreased from 1.81 to 1.23, P less than 0.005). 3. GR43175 (100 micrograms kg-1, i.v., rats; 30 micrograms kg-1, guinea-pigs) decreased the leakage of radiolabelled albumin from 163% to 119% (P less than 0.005, guinea-pig) or from 174 to 118% (P less than 0.05, rat) above vehicle-treated controls when injected ten minutes before systemic capsaicin treatment (0.5 or 1 mumol kg-1, i.v.). 4. GR43175 (30-300 micrograms kg-1) did not block plasma protein extravasation within extracranial tissues of rats and guinea-pigs innervated by the trigeminal nerve (conjunctiva, eyelid and lip). 5. The protein leakage which followed the i.v. administration of 5-HT (1 mumol kg-1) or neuropeptides which mediate neurogenic plasma extravasation, substance P (0.3 nmol kg-1 or 1 nmol kg-1) and neurokinin A (1 nmol kg-1), was not blocked by GR43175 (100, 300 micrograms kg-1) despite the presence of leakage in amounts equivalent to that following neurogenic stimulation. 6. GR43175 (100 micrograms kg-1) decreased bradykinin (10 mumol kg-1)-induced extravasation from 142 to 115% above vehicle-treated animals (P less than 0.05). 7. These results demonstrate an important action of GR43175 on neurogenic mechanisms in dural blood vessels. Since the ergot alkaloids possess a similar profile of drug activity, it is suggested that drugs useful in the treatment of acute vascular headaches may share a similar mechanism of action.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2158835      PMCID: PMC1917483          DOI: 10.1111/j.1476-5381.1990.tb14679.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Observations on chemical excitants of cutaneous pain in man.

Authors:  D ARMSTRONG; R M L DRY; C A KEELE; J W MARKHAM
Journal:  J Physiol       Date:  1953-05-28       Impact factor: 5.182

2.  Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation.

Authors:  F Lembeck; P Holzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

3.  Nerve fibres and their terminals of the dura mater encephali of the rat.

Authors:  K H Andres; M von Düring; K Muszynski; R F Schmidt
Journal:  Anat Embryol (Berl)       Date:  1987

Review 4.  The involvement of trigeminal substance P neurons in cluster headache. An hypothesis.

Authors:  J E Hardebo
Journal:  Headache       Date:  1984-11       Impact factor: 5.887

5.  Immunohistochemical localization and dilatatory effect of substance P on human cerebral vessels.

Authors:  L Edvinsson; R Uddman
Journal:  Brain Res       Date:  1982-01-28       Impact factor: 3.252

6.  Neurotransmitters and the fifth cranial nerve: is there a relation to the headache phase of migraine?

Authors:  M A Moskowitz; J F Reinhard; J Romero; E Melamed; D J Pettibone
Journal:  Lancet       Date:  1979-10-27       Impact factor: 79.321

7.  Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine.

Authors:  A Doenicke; J Brand; V L Perrin
Journal:  Lancet       Date:  1988-06-11       Impact factor: 79.321

8.  Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain.

Authors:  S Markowitz; K Saito; M A Moskowitz
Journal:  J Neurosci       Date:  1987-12       Impact factor: 6.167

9.  Trigeminal origin of beta-preprotachykinin products in feline pial blood vessels.

Authors:  K Saito; S Greenberg; M A Moskowitz
Journal:  Neurosci Lett       Date:  1987-04-23       Impact factor: 3.046

10.  The neurobiology of vascular head pain.

Authors:  M A Moskowitz
Journal:  Ann Neurol       Date:  1984-08       Impact factor: 10.422

View more
  77 in total

1.  [PET and Doppler sonography in headaches].

Authors:  A May; C Weiller
Journal:  Schmerz       Date:  1996-06-17       Impact factor: 1.107

2.  Influence of age on the GH response to sumatriptan administration in man.

Authors:  V Coiro; R Volpi; C Davoli; G Caffarri; P Chiodera
Journal:  J Neural Transm Gen Sect       Date:  1995

3.  CP-93,129, a potent and selective 5-HT1B receptor agonist blocks neurogenic plasma extravasation within rat but not guinea-pig dura mater.

Authors:  T Matsubara; M A Moskowitz; B Byun
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

Review 4.  Rationale for the use of 5-HT1-like agonists in the treatment of migraine.

Authors:  W Feniuk; P P Humphrey; M J Perren; H E Connor; E T Whalley
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

Review 5.  The cerebellum and migraine.

Authors:  Maurice Vincent; Nouchine Hadjikhani
Journal:  Headache       Date:  2007-06       Impact factor: 5.887

6.  Sensory nerve-mediated relaxation of guinea-pig isolated pulmonary artery: prejunctional modulation by alpha 2-adrenoceptor agonists but not sumatriptan.

Authors:  A Butler; S P Worton; C T O'Shaughnessy; H E Connor
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

7.  Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea.

Authors:  S J Lydford; K McKechnie
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

8.  Effect of a 5-HT1 receptor agonist, CP-122,288, on oedema formation induced by stimulation of the rat saphenous nerve.

Authors:  R Kajekar; P Gupta; N B Shepperson; S D Brain
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

Review 9.  Does sumatriptan cross the blood-brain barrier in animals and man?

Authors:  Peer Carsten Tfelt-Hansen
Journal:  J Headache Pain       Date:  2009-12-10       Impact factor: 7.277

10.  Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan.

Authors:  M O den Boer; C M Villalón; J P Heiligers; P P Humphrey; P R Saxena
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.